Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.
J Immunother Cancer. 2024 Jan 31;12(1):e008232. doi: 10.1136/jitc-2023-008232.
J Immunother Cancer. 2024.
PMID: 38296594
Free PMC article.
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis.
Nahar KJ, Marsh-Wakefield F, Rawson RV, Gide TN, Ferguson AL, Allen R, Quek C, da Silva IP, Tattersal S, Kiely CJ, Sandanayake N, Carlino MS, McCaughan G, Wilmott JS, Scolyer RA, Long GV, Menzies AM, Palendira U.
Nahar KJ, et al.
JCI Insight. 2022 Nov 8;7(21):e157839. doi: 10.1172/jci.insight.157839.
JCI Insight. 2022.
PMID: 36173679
Free PMC article.
Item in Clipboard
Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab.
Nahar KJ, Rawson RV, Ahmed T, Tattersall S, Sandanayake N, Kiely CJ, Lo S, Carlino M, Palendira U, Scolyer RA, Long GV, Menzies AM.
Nahar KJ, et al.
J Immunother Cancer. 2020 Nov;8(2):e001488. doi: 10.1136/jitc-2020-001488.
J Immunother Cancer. 2020.
PMID: 33234603
Free PMC article.
Item in Clipboard
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy.
Attrill GH, Owen CN, Ahmed T, Vergara IA, Colebatch AJ, Conway JW, Nahar KJ, Thompson JF, Pires da Silva I, Carlino MS, Menzies AM, Lo S, Palendira U, Scolyer RA, Long GV, Wilmott JS.
Attrill GH, et al. Among authors: nahar kj.
J Immunother Cancer. 2022 Jun;10(6):e004771. doi: 10.1136/jitc-2022-004771.
J Immunother Cancer. 2022.
PMID: 35688560
Free PMC article.
Item in Clipboard
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.
Bai X, Attrill GH, Gide TN, Ferguson PM, Nahar KJ, Shang P, Vergara IA, Palendira U, da Silva IP, Carlino MS, Menzies AM, Long GV, Scolyer RA, Wilmott JS, Quek C.
Bai X, et al. Among authors: nahar kj.
Nat Commun. 2024 Apr 8;15(1):3014. doi: 10.1038/s41467-024-47301-9.
Nat Commun. 2024.
PMID: 38589406
Free PMC article.
Item in Clipboard
Cite
Cite